Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Besedovsky

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Annals of the New York Academy of Sciences|July 25, 2012
TGF-β neutralization abrogates the inhibited DHEA production mediated by factors released from M. tuberculosis-stimulated PBMCLuciano D'Attilio, Verónica V Bozza, Natalia Santucci, et al.
Frontiers in Bioscience (Landmark Edition)|December 30, 2024
Combined Use of Intranasal Methylprednisolone and Allopregnanolone: Revisiting Anti-inflammatory and Remyelinating Treatment in a Murine Model of Multiple SclerosisIván Nicolás Pérez-Osorio, José Alejandro Espinosa-Cerón, Camila Álvarez-Gutiérrez, et al.
Neuroimmunomodulation|February 8, 2014
Helminth infection alters mood and short-term memory as well as levels of neurotransmitters and cytokines in the mouse hippocampusJorge Morales-Montor, Ofir Picazo, Hugo Besedovsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 17, 2021
Nose-to-Brain Delivery of Dexamethasone: Biodistribution Studies in MiceIván Nicolás Pérez-Osorio, Alejandro Espinosa, Manuel Giraldo Velázquez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 8, 2020
Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke ModelAlejandro Espinosa, Gabriela Meneses, Anahí Chavarría, et al.
Neuroimmunomodulation|July 25, 2018
Treatment-Resistant Human Extraparenchymal Neurocysticercosis: An Immune-Inflammatory Approach to Cysticidal Treatment OutcomeAsiel Arce-Sillas, Graciela Cárdenas, Diana Álvarez-Luquín, et al.
Annals of the New York Academy of Sciences|July 25, 2012
Changes in the immune and endocrine responses of patients with pulmonary tuberculosis undergoing specific treatmentBettina Bongiovanni, Ariana Díaz, Luciano D'Attilio, et al.
Pathogens and Disease|September 1, 2017
The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responsesAriana Díaz, Bettina Bongiovanni, Luciano D'Attilio, et al.
Trials|February 15, 2022
Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patientsGraciela Cárdenas, María Chávez-Canales, Ana María Espinosa, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Annals of the New York Academy of Sciences|July 25, 2012
TGF-β neutralization abrogates the inhibited DHEA production mediated by factors released from M. tuberculosis-stimulated PBMCLuciano D'Attilio, Verónica V Bozza, Natalia Santucci, et al.
Frontiers in Bioscience (Landmark Edition)|December 30, 2024
Combined Use of Intranasal Methylprednisolone and Allopregnanolone: Revisiting Anti-inflammatory and Remyelinating Treatment in a Murine Model of Multiple SclerosisIván Nicolás Pérez-Osorio, José Alejandro Espinosa-Cerón, Camila Álvarez-Gutiérrez, et al.
Neuroimmunomodulation|February 8, 2014
Helminth infection alters mood and short-term memory as well as levels of neurotransmitters and cytokines in the mouse hippocampusJorge Morales-Montor, Ofir Picazo, Hugo Besedovsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 17, 2021
Nose-to-Brain Delivery of Dexamethasone: Biodistribution Studies in MiceIván Nicolás Pérez-Osorio, Alejandro Espinosa, Manuel Giraldo Velázquez, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 8, 2020
Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke ModelAlejandro Espinosa, Gabriela Meneses, Anahí Chavarría, et al.
Neuroimmunomodulation|July 25, 2018
Treatment-Resistant Human Extraparenchymal Neurocysticercosis: An Immune-Inflammatory Approach to Cysticidal Treatment OutcomeAsiel Arce-Sillas, Graciela Cárdenas, Diana Álvarez-Luquín, et al.
Annals of the New York Academy of Sciences|July 25, 2012
Changes in the immune and endocrine responses of patients with pulmonary tuberculosis undergoing specific treatmentBettina Bongiovanni, Ariana Díaz, Luciano D'Attilio, et al.
Pathogens and Disease|September 1, 2017
The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responsesAriana Díaz, Bettina Bongiovanni, Luciano D'Attilio, et al.
Trials|February 15, 2022
Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patientsGraciela Cárdenas, María Chávez-Canales, Ana María Espinosa, et al.
Pageof 3